Cover Image
市場調查報告書

生物資訊學:各種技術和全球市場

Bioinformatics: Technologies and Global Markets

出版商 BCC Research 商品編碼 268909
出版日期 內容資訊 英文 158 Pages
訂單完成後即時交付
價格
Back to Top
生物資訊學:各種技術和全球市場 Bioinformatics: Technologies and Global Markets
出版日期: 2016年01月29日 內容資訊: 英文 158 Pages
簡介

全球生物資訊學的市場在2013年寫下36億美元的記錄,2014年達到41億美元的規模。預測從2014年到2019年將以14.2%的年複合成長率推移,從2015年的47億美元,成長到2019年80億美元的規模

当レポートでは、世界のバイオインフォマティクス市場について調査し、バイオインフォマティクスの定義と目標、膨大な生物学的データとその用途、データの生成・管理・解析・処理とコンピューティング技術、各種オミクス研究におけるデータ利用、医薬品の研究開発におけるバイオインフォマティクスの利用、カテゴリー・用途・地域別の市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

本報告提供全球生物資訊學市場相關調查,提供您生物資訊學定義與目標,龐大的生物學資料及其用途,資料的生成·管理·分析·處理和運算技術,各種體學研究的資料利用,醫藥品的研究開發的生物資訊學的利用,各類別·用途·地區的市場規模變化與預測,競爭環境,並彙整主要企業的簡介等資訊。

第1章 簡介

第2章 摘要整理

第3章 巨量資料和生物資訊學

  • 生物資訊學的目標
  • 生物學的資料來源
    • 系統生物學的生物資訊學
    • PRECISION MEDICINE (精密醫療)
    • 藥物開發上的生物資訊學
    • 化學資訊學
    • 次世代定序
    • 總體基因體學
    • 資料管理系統
  • 市場趨勢
    • PRECISION MEDICINE (精密醫療) 和生物標記的鑑定
    • 雲端基礎的解決方案
    • 價值為基礎的照護的轉變
  • 市場課題
    • 資料整合
    • 資料的可靠性·標準化
    • 端到端的工作流程
  • 目前市場
  • 各地區市場
  • 各類別市場
    • 公共資金
    • 民間資金
  • 各用途市場

第4章 生物資訊學:資料生成與資料管理

  • 資訊超載
    • 資料數量
    • 資料的多樣性
    • 資料的速度
    • 資料的正確度
  • 巨量資料世代的技術
  • 基因學的演進
    • 定序基因學
    • 功能基因學
  • 蛋白質體學的演進
    • 定量的蛋白質體學
    • 定性的蛋白質體學
    • 結構蛋白質體學
    • 相互作用蛋白質體學
    • 轉錄的演進
  • 代謝體學的演進
  • 化學資訊學的演進
  • 新興技術
    • 總體基因體學的演進
  • 表觀基因 演進
  • 藥理基因學的演進
    • 藥理基因學和PRECISION MEDICINE (精密醫療)
    • 價值為基礎的決策
    • 藥理基因學和R&D
    • iSAEC (INTERNATIONAL SERIOUS ADVERSE EVENTS CONSORTIUM)
    • 藥理基因學軟體
  • 毒理基因體學的演進
    • TOXCAST計劃
    • 客製化毒理基因體學平台
  • 資料庫管理服務
  • 市場動態

第5章 生物資訊學:資料分析和軟體

  • 簡介
  • 資料分析軟體
  • 生物模擬 model
  • 市場分析

第6章 生物資訊學:資料處理和儲存

  • 對差距的關注
  • 資訊技術基礎設施
  • 高性能運算
  • 高性能電腦叢集
    • 雲端運算
    • DaaS (DATA AS A SERVICE)
    • IaaS (INFRASTRUCTURE AS A SERVICE)
    • PaaS (PLATFORM AS A SERVICE)
    • SaaS (SOFTWARE AS A SERVICE)
    • SaaS (SECURITY AS A SERVICE)
    • 雲端運算的課題
    • 雲端運算的未來
  • 市場分析

第7章 對醫藥品R&D的生物資訊學的引進

  • 簡介
  • 藥物研發·藥物開發過程
  • 前臨床研究:藥物研發階段
    • 標的鑑定
    • 標的驗證
    • 先導藥物的鑑定
    • 透過電腦支援的藥物設計
    • 領導的最佳化
    • 臨床研究:藥物開發
    • 前臨床實驗
    • 實驗室資訊管理系統
    • 電子實驗室筆記本
    • 新藥申請的調查
    • 臨床試驗
    • 臨床試驗設計·資料對照的生物資訊學
    • 新藥的申請
    • 新藥的認證
    • 上市後的持續性研究·第四階段臨床試驗
    • EHR (電子病歷)
    • 行動醫療技術
    • 近幾年的醫藥品·生物資訊學經營者的聯盟·聯盟等
    • 總論

第8章 市場趨勢·分析

  • 北美
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 瑞士
  • 亞太地區
  • 印度
  • 中國
  • 總論

第9章 企業簡介

  • 3RD MILLENNIUM INC.
  • ASTRID BIOSCIENCE GMBH
  • BIOBASE GMBH
  • BIOMATTERS LTD.
  • CLC BIOINFORMATICS
  • CONEXIO GENOMICS PRIVATE LTD.
  • COMPUGEN LTD.
  • DASSAULT SYSTEMES SA
  • DNASTAR INC.
  • GEOSPIZA INC.
  • GENOMATIX SOFTWARE GMBH
  • GVK BIOSCIENCES PRIVATE LTD.
  • GENOLOGICS LIFESCIENCES SOFTWARE INC.
  • GENEDATA AG
  • GENEVA BIOFORMATICS (GENEBIO) SA
  • GNS HEALTHCARE INC.
  • ILLUMINA INC.
  • MOLECULAR CONNECTIONS PRIVATE LTD.
  • MOLECULAR NETWORKS GMBH
  • NONLINEAR DYNAMICS LTD.
  • OCIMUM BIOSOLUTIONS LTD.
  • PERKIN ELMER INFORMATICS INC.
  • PERSONALIS INC.
  • SMARTGENE SERVICES SARL
  • REAL TIME GENOMICS INC.

第10章 用語

第11章 參考資料

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BIO051C

REPORT HIGHLIGHTS

The global bioinformatic market was $3.6 billion and $4.1 billion in 2013 and 2014, respectively. This market is expected to reach $8.0 billion in 2019 from $4.7 billion in 2015 at a compound annual growth rate of 14.2% for the period 2014-2019.

The report provides:

  • An overview of the global market for bioinformatics based on geography, category and application.
  • Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2019.
  • Technological descriptions and patenting trends in bioinformatics.
  • Analysis of the market's dynamics, including opportunities, drivers, and restraints.
  • Examination of the economic environment effecting the deployment of bioinformatics.
  • Discussion of other influential factors, such as R&D spending in the pharmaceutical sector, the growth of agrobiotechnology, and the expanded use of microbial genomics.
  • Comprehensive company profiles of major players in the industry.

SCOPE OF REPORT

The scope of the study encompasses the global bioinformatic market based on geography, category and application. It provides a detailed analysis of recent advances in ‘omic technologies and examines their impact on the bioinformatic market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industry to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of leading countries, companies and technologies that will drive the field forward.

ANALYST'S CREDENTIALS

Dr. C.L. Barton has more than 10 years' practical pharmaceutical research experience with a leading pharmaceutical company and is a Pan-European pharmaceutical analyst with a European Bank.

Dr. C.L. Barton Ltd. aims to provide independent, tailor-made, pharmaceutical thematic research to investment houses. Where applicable, the research reports combine independent scientific analysis with patient- and prescription-based models to forecast the potential sales growth of key developmental drugs and isolate the key drivers within the pharmaceutical sector.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • SCOPE OF REPORT
  • INTENDED AUDIENCE
  • INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL BIOINFORMATIC MARKET BY REGION, 2013-2019 ($ MILLIONS)

CHAPTER 3 - BIG DATA: WHAT TO DO WITH IT?

  • GOAL OF BIOINFORMATICS
    • FIGURE 1 RELATIONSHIP OF BIOINFORMATICS WITH 'OMIC TECHNOLOGIES
  • BIOLOGICAL DATA SOURCES
    • BIOINFORMATICS IN SYSTEMS BIOLOGY
      • FIGURE 2 SCHEMATIC REPRESENTATION OF BIOLOGY SYSTEMS AND TRANSLATIONAL BIOINFORMATICS
    • PRECISION MEDICINE
      • FIGURE 3 PRINCIPLES OF PRECISION MEDICINE
    • BIOINFORMATICS IN DRUG DEVELOPMENT
      • FIGURE 4 APPLICATIONS OF BIOINFORMATICS ON DRUG DEVELOPMENT
    • CHEMINFORMATICS
    • NEXT-GENERATION SEQUENCING
    • METAGENOMICS
    • DATA MANAGEMENT SYSTEMS
  • MARKET TRENDS
    • TABLE 1: U.S. FOOD AND DRUG ADMINISTRATION AND EUROPEAN MEDICINES AGENCY DRUG APPROVALS, 2009-2014
    • PRECISION MEDICINE AND BIOMARKER IDENTIFICATION
    • CLOUD-BASED SOLUTIONS
    • SHIFT TOWARD VALUE-BASED CARE
  • MARKET CHALLENGES
    • DATA INTEGRATION
    • DATA RELIABILITY AND STANDARDIZATION
    • END-TO-END WORKFLOWS
  • CURRENT MARKET
  • MARKET BY REGION
    • TABLE 2: GLOBAL BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • MARKET BY CATEGORY
    • PUBLIC FUNDING
      • TABLE 3: PUBLIC FUNDING PROGRAMS, 2005-2014
    • PRIVATE FUNDING
      • TABLE 4: GLOBAL BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019 ($ MILLIONS)
  • MARKET BY APPLICATION
    • TABLE 5: GLOBAL BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS)

CHAPTER 4 - BIOINFORMATICS: DATA GENERATION AND DATA MANAGEMENT

  • INFORMATION OVERLOAD
    • FIGURE 5: FOUR DIMENSIONS OF BIG DATA
    • DATA VOLUME
    • DATA VARIETY
    • DATA VELOCITY
    • DATA VERACITY
  • TECHNOLOGIES BEHIND BIG DATA GENERATION
  • GENOMIC ADVANCES
    • SEQUENCING GENOMICS
      • Metagenomics
      • Exponential Growth in Next-Generation Sequencing Software Tools
    • FUNCTIONAL GENOMICS
      • Functional Genomics in Drug Discovery
      • CRISPR Cas9 System
  • PROTEOMIC ADVANCES
    • QUALITATIVE PROTEOMICS
    • QUANTITATIVE PROTEOMICS
    • STRUCTURAL PROTEOMICS
      • Protein Structure Initiative
      • Structural Genomic Consortium
    • INTERACTION PROTEOMICS
      • Application in Drug Discovery
      • Bottom-Up versus Top-Down Proteomics
        • FIGURE 6: TOP-DOWN PROTEOMIC APPROACH
      • Emergence of Glycomics
      • Human Proteome Organization and the Human Proteome Project Initiative
    • TRANSCRIPTOMIC ADVANCES
      • RNA Sequencing
      • Co-Expression and Single-Cell RNA-Seq
  • METABOLOMIC ADVANCES
    • TABLE 6: COMMERCIALLY AVAILABLE METABOLOMIC SOFTWARE
    • TABLE 7: OPEN-ACCESS TOOLS FOR COMPLEX LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY DATA ANALYSIS
  • CHEMINFORMATIC ADVANCES
    • TABLE 8: CHEMINFORMATIC SOFTWARE SOLUTIONS FOR DRUG RESEARCH AND DEVELOPMENT
  • EMERGING TECHNOLOGIES
    • METAGENOMIC ADVANCES
      • TABLE 9: BIOINFORMATIC TOOLS FOR METAGENOMIC STUDIES
  • EPIGENOMIC ADVANCES
  • PHARMACOGENOMIC ADVANCES
    • PHARMACOGENOMICS AND PRECISION MEDICINE
    • VALUE-BASED DECISIONS
    • PHARMACOGENOMICS AND RESEARCH AND DEVELOPMENT
      • TABLE 10: BIOINFORMATIC TOOLS FOR PHARMACOGENOMIC STUDIES
    • INTERNATIONAL SERIOUS ADVERSE EVENTS CONSORTIUM
    • PHARMACOGENOMIC SOFTWARE
      • TABLE 11: BIOINFORMATIC TOOLS FOR PHARMACOGENOMIC SOFTWARE
  • TOXICOGENOMIC ADVANCES
    • TOXCAST COMPUTATIONAL TOXICOLOGY RESEARCH PROGRAM
    • CUSTOMIZED TOXICOGENOMIC PLATFORMS
  • DATABASE MANAGEMENT SERVICES
    • TABLE 12: ARCHIVAL DATABASES
    • TABLE 13: CURATIVE DATABASES
    • TABLE 14: COMMERCIALLY AVAILABLE DATABASES
  • MARKET DYNAMICS

CHAPTER 5 - BIOINFORMATICS: DATA ANALYSIS AND SOFTWARE

  • INTRODUCTION
  • DATA ANALYSIS SOFTWARE
    • FIGURE 7: EUROPEAN BIOINFORMATIC INSTITUTE SOFTWARE SOLUTIONS
    • TABLE 15: SOFTWARE FOR BIOLOGICAL ANALYSIS
    • TABLE 16: POPULAR COMMERCIALLY AVAILABLE BIOINFORMATIC PROGRAMS FOR NEXT-GENERATION SEQUENCING ANALYSIS
  • BIOSIMULATION MODELS
  • MARKET ANALYSIS

CHAPTER 6 - BIOINFORMATICS: DATA PROCESSING AND STORAGE

  • MIND THE GAP
    • FIGURE 8: EVOLUTION OF INFORMATION TECHNOLOGY INFRASTRUCTURE
  • INFORMATION TECHNOLOGY INFRASTRUCTURE
    • TABLE 17: TOP 20 HARDWARE COMPANIES, 2010 ($MM/%)
  • HIGH-PERFORMANCE COMPUTING
    • TABLE 18: TOP SUPERCOMPUTERS, AS OF 2015
  • HIGH-PERFORMANCE COMPUTER CLUSTERS
    • CLOUD COMPUTING
      • FIGURE 9: SCHEMATIC REPRESENTATION OF CLOUD COMPUTING SERVICES
    • DATA AS A SERVICE
    • INFRASTRUCTURE AS A SERVICE
    • PLATFORM AS A SERVICE
    • SOFTWARE AS A SERVICE
      • TABLE 19: SOFTWARE AS A SERVICE RESOURCE
    • SECURITY AS A SERVICE
    • CLOUD COMPUTING CHALLENGES
    • FUTURE OF CLOUD COMPUTING
  • MARKET ANALYSIS

CHAPTER 7 - BIOINFORMATIC APPLICATIONS IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT

  • INTRODUCTION
    • TABLE 20: LEADING BIOINFORMATICS DATABASES
  • DRUG DISCOVERY AND DEVELOPMENT PROCESS
    • FIGURE 10: PHASES IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS
  • PRECLINICAL RESEARCH: DRUG DISCOVERY PHASE
    • TARGET IDENTIFICATION
    • TARGET VALIDATION
      • Role of Bioinformatics in Target Identification and Validation
        • TABLE 21: LEADING DRUG TARGET DATABASES
    • LEAD IDENTIFICATION
    • COMPUTER-AIDED DRUG DESIGN
      • FIGURE 11: BIOINFORMATIC INTERDISCIPLINARY NATURE
      • TABLE 22: COMPUTER SIMULATION PLATFORMS
    • LEAD OPTIMIZATION
    • CLINICAL RESEARCH: DRUG DEVELOPMENT
    • PRECLINICAL EXPERIMENTS
    • LABORATORY INFORMATION MANAGEMENT SYSTEMS
      • TABLE 23: LEADING LABORATORY INFORMATION MANAGEMENT SYSTEM PROVIDERS
    • ELECTRONIC LABORATORY NOTEBOOKS
      • FIGURE 12: INFORMATION SYSTEMS WITHIN THE LABORATORY ARCHITECTURE
      • TABLE 24: ELECTRONIC NOTEBOOKS USED WITHIN THE RESEARCH AND DEVELOPMENT ENVIRONMENT
      • TABLE 25: ELECTRONIC LABORATORY NOTEBOOKS USED WITHIN SPECIFIC AREAS OF BIOLOGY
    • INVESTIGATIONAL NEW DRUG APPLICATION
    • CLINICAL TRIALS
    • BIOINFORMATICS IN CLINICAL TRIAL DESIGN AND DATA COLLATION
      • TABLE 26: LEADING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION AND TOXICITY PREDICTION TOOLS
    • NEW DRUG APPLICATION
    • NEW DRUG APPLICATION APPROVAL
      • TABLE 27: DRUG DEVELOPMENT PROCESS OVERVIEW
    • POST-LAUNCH ONGOING STUDIES AND PHASE IV CLINICAL TRIALS
    • ELECTRONIC HEALTH RECORDS
      • TABLE 28: LEADING ELECTRONIC HEALTH RECORD PROVIDERS, 2013
    • MOBILE HEALTH TECHNOLOGIES
      • TABLE 29: MEDICAL APPLICATIONS FOR HEALTHCARE PROFESSIONALS
    • RECENT PHARMACEUTICAL AND BIOINFORMATIC ALLIANCES AND PARTNERSHIPS
      • TABLE 30: PHARMACEUTICAL AND BIOINFORMATIC PARTNERSHIPS AND ALLIANCES
    • CONCLUSIONS

CHAPTER 8 - MARKET TRENDS AND ANALYSIS

  • NORTH AMERICA
    • TABLE 31: NORTH AMERICAN BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
  • UNITED STATES
    • TABLE 32: LEADING BIOINFORMATIC COMPANIES IN THE U.S.
    • TABLE 33: TOP 15 VENTURE CAPITAL COMPANIES MOST ACTIVE IN THE LIFE SCIENCE SECTOR, THROUGH 2012
    • TABLE 34: U.S. BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 35: U.S. BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019 ($ MILLIONS)
  • CANADA
    • TABLE 36: CANADIAN BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019 ($ MILLIONS)
    • TABLE 37: LEADING CANADIAN BIOINFORMATIC COMPANIES
    • TABLE 38: CANADIAN BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • EUROPE
    • TABLE 39: EUROPEAN BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: LEADING EUROPEAN BIOINFORMATIC COMPANIES
  • U.K.
    • TABLE 41: U.K. BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 42: U.K. BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
  • GERMANY
    • TABLE 43: GERMAN BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 44: GERMAN BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
  • SWITZERLAND
    • TABLE 45: SWISS BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 46: SWISS BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
  • ASIA-PACIFIC
    • TABLE 47: ASIA-PACIFIC BIOINFORMATIC MARKET BY REGION,THROUGH 2019 ($ MILLIONS)
  • INDIA
    • TABLE 48: INDIAN BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • FIGURE 13: KEY AREAS OF RESEARCH UTILIZING BIOINFORMATICS
    • TABLE 49: LEADING INDIAN BIOINFORMATIC COMPANIES
    • TABLE 50: INDIAN BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
  • CHINA
    • TABLE 51: CHINESE BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 52: CHINESE BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
  • CONCLUSIONS

CHAPTER 9 - COMPANY PROFILES

  • 3RD MILLENNIUM INC.
  • ASTRID BIOSCIENCE GMBH
  • BIOBASE GMBH
  • BIOMATTERS LTD.
  • CLC BIOINFORMATICS
  • CONEXIO GENOMICS PRIVATE LTD.
  • COMPUGEN LTD.
  • DASSAULT SYSTEMES SA
  • DNASTAR INC.
  • GEOSPIZA INC.
  • GENOMATIX SOFTWARE GMBH
  • GVK BIOSCIENCES PRIVATE LTD.
  • GENOLOGICS LIFESCIENCES SOFTWARE INC.
  • GENEDATA AG
  • GENEVA BIOFORMATICS (GENEBIO) SA
  • GNS HEALTHCARE INC.
  • ILLUMINA INC.
  • MOLECULAR CONNECTIONS PRIVATE LTD.
  • MOLECULAR NETWORKS GMBH
  • NONLINEAR DYNAMICS LTD.
  • OCIMUM BIOSOLUTIONS LTD.
  • PERKIN ELMER INFORMATICS INC.
  • PERSONALIS INC.
  • SMARTGENE SERVICES SARL
  • REAL TIME GENOMICS INC.

CHAPTER 10 - APPENDIX ONE: ACRONYMS

CHAPTER 11 - REFERENCES

  • ENDNOTES

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: U.S. FOOD AND DRUG ADMINISTRATION AND EUROPEAN MEDICINES AGENCY DRUG APPROVALS, 2009-2014
    • TABLE 2: GLOBAL BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 3: PUBLIC FUNDING PROGRAMS, 2005-2014
    • TABLE 4: GLOBAL BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019 ($ MILLIONS)
    • TABLE 5: GLOBAL BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 6: COMMERCIALLY AVAILABLE METABOLOMIC SOFTWARE
    • TABLE 7: OPEN-ACCESS TOOLS FOR COMPLEX LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY DATA ANALYSIS
    • TABLE 8: CHEMINFORMATIC SOFTWARE SOLUTIONS FOR DRUG RESEARCH AND DEVELOPMENT
    • TABLE 9: BIOINFORMATIC TOOLS FOR METAGENOMIC STUDIES
    • TABLE 10: BIOINFORMATIC TOOLS FOR PHARMACOGENOMIC STUDIES
    • TABLE 11: BIOINFORMATIC TOOLS FOR PHARMACOGENOMIC SOFTWARE
    • TABLE 12: ARCHIVAL DATABASES
    • TABLE 13: CURATIVE DATABASES
    • TABLE 14: COMMERCIALLY AVAILABLE DATABASES
    • TABLE 15: SOFTWARE FOR BIOLOGICAL ANALYSIS
    • TABLE 16: POPULAR COMMERCIALLY AVAILABLE BIOINFORMATIC PROGRAMS FOR NEXT-GENERATION SEQUENCING ANALYSIS
    • TABLE 17: TOP 20 HARDWARE COMPANIES, 2010 ($MM/%)
    • TABLE 18: TOP SUPERCOMPUTERS, AS OF 2015
    • TABLE 19: SOFTWARE AS A SERVICE RESOURCE
    • TABLE 20: LEADING BIOINFORMATICS DATABASES
    • TABLE 21: LEADING DRUG TARGET DATABASES
    • TABLE 22: COMPUTER SIMULATION PLATFORMS
    • TABLE 23: LEADING LABORATORY INFORMATION MANAGEMENT SYSTEM PROVIDERS
    • TABLE 24: ELECTRONIC NOTEBOOKS USED WITHIN THE RESEARCH AND DEVELOPMENT ENVIRONMENT
    • TABLE 25: ELECTRONIC LABORATORY NOTEBOOKS USED WITHIN SPECIFIC AREAS OF BIOLOGY
    • TABLE 26: LEADING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION AND TOXICITY PREDICTION TOOLS
    • TABLE 27: DRUG DEVELOPMENT PROCESS OVERVIEW
    • TABLE 28: LEADING ELECTRONIC HEALTH RECORD PROVIDERS, 2013
    • TABLE 29: MEDICAL APPLICATIONS FOR HEALTHCARE PROFESSIONALS
    • TABLE 30: PHARMACEUTICAL AND BIOINFORMATIC PARTNERSHIPS AND ALLIANCES
    • TABLE 31: NORTH AMERICAN BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 32: LEADING BIOINFORMATIC COMPANIES IN THE U.S.
    • TABLE 33: TOP 15 VENTURE CAPITAL COMPANIES MOST ACTIVE IN THE LIFE SCIENCE SECTOR, THROUGH 2012
    • TABLE 34: U.S. BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 35: U.S. BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019 ($ MILLIONS)
    • TABLE 36: CANADIAN BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019 ($ MILLIONS)
    • TABLE 37: LEADING CANADIAN BIOINFORMATIC COMPANIES
    • TABLE 38: CANADIAN BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 39: EUROPEAN BIOINFORMATIC MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: LEADING EUROPEAN BIOINFORMATIC COMPANIES
    • TABLE 41: U.K. BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 42: U.K. BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
    • TABLE 43: GERMAN BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 44: GERMAN BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
    • TABLE 45: SWISS BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 46: SWISS BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
    • TABLE 47: ASIA-PACIFIC BIOINFORMATIC MARKET BY REGION,THROUGH 2019 ($ MILLIONS)
    • TABLE 48: INDIAN BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 49: LEADING INDIAN BIOINFORMATIC COMPANIES
    • TABLE 50: INDIAN BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)
    • TABLE 51: CHINESE BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019 ($ MILLIONS)
    • TABLE 52: CHINESE BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019 ($ MILLIONS)

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL BIOINFORMATIC MARKET BY REGION, 2013-2019 ($ MILLIONS)
    • FIGURE 1: RELATIONSHIP OF BIOINFORMATICS WITH 'OMIC TECHNOLOGIES
    • FIGURE 2: SCHEMATIC REPRESENTATION OF BIOLOGY SYSTEMS AND TRANSLATIONAL BIOINFORMATICS
    • FIGURE 3: PRINCIPLES OF PRECISION MEDICINE
    • FIGURE 4: APPLICATIONS OF BIOINFORMATICS ON DRUG DEVELOPMENT
    • FIGURE 5: FOUR DIMENSIONS OF BIG DATA
    • FIGURE 6: TOP-DOWN PROTEOMIC APPROACH
    • FIGURE 7: EUROPEAN BIOINFORMATIC INSTITUTE SOFTWARE SOLUTIONS
    • FIGURE 8: EVOLUTION OF INFORMATION TECHNOLOGY INFRASTRUCTURE
    • FIGURE 9: SCHEMATIC REPRESENTATION OF CLOUD COMPUTING SERVICES
    • FIGURE 10: PHASES IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS
    • FIGURE 11: BIOINFORMATIC INTERDISCIPLINARY NATURE
    • FIGURE 12: INFORMATION SYSTEMS WITHIN THE LABORATORY ARCHITECTURE
    • FIGURE 13: KEY AREAS OF RESEARCH UTILIZING BIOINFORMATICS 128
Back to Top